Johnson & Johnson Admits Misleading U.S. Motrin Recall

WASHINGTON, Sept 30 (Reuters) - Already battered by a wave of product recalls, Johnson & Johnson (JNJ.N) acknowledged on Thursday it had misled consumers and U.S. regulators as it quietly removed its Motrin painkiller from the market.